Cyclooxygenase-2 in dukes B colon cancer

Hepato-Gastroenterology

Volumn 58, Issue 107-108, 2011, Pages 763-768

  Šundov, Željko ^a   Kunac, Nenad ^a   Čapkun, Vesna ^a   Kalebic, Marija ^b   Družijanić, Nikica ^a   Puljak, Livia ^a   Tomić, Snježana ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

^b Department of Emergency Medicine ^*  (Croatia)

Author keywords

Colon cancer; COX 2; Immunohistochemistry; Prognosis

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; COLON CARCINOMA; CONTROLLED STUDY; DUKES B COLON CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL TIME;

ADULT; AGED; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 80051657765     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Murray T, Ward E, Samules A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Barozzi C, Ravaioli M, D'Errico A, Grazi GL, Poggioli G, Cavrini G, Mazziotti A, Grigioni WF: Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 2002;94:647-57. (Pubitemid 34132292)
3. Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM: Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 2000;164:361-70.
4. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40. (Pubitemid 27157312)
5. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16. (Pubitemid 28257578)
6. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83:493-501.
7. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN: Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58:362-6. (Pubitemid 28047080)
8. Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH, Terry E, Morrow JD, Coffey RJ: Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 2003;63:1748-51.
9. Cao Y, Prescott SM: Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002; 190:279-86. (Pubitemid 34111968)
10. DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD: G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996; 56:733-7. (Pubitemid 26060513)
11. Tuynman JB, Peppelenbosch MP, Richel DJ: COX-2 inhibition as a tool to treat and prevent colorectal cancer. Crit Rev Oncol Hematol 2004; 52:81-101. (Pubitemid 39410538)
12. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333:609-14.
13. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW, Jr: Aspirin use and risk of fatal cancer. Cancer Res 1993; 53:1322-7. (Pubitemid 23097110)
14. Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94:252-66. (Pubitemid 34196319)
15. Tuynman JB, Buskens CJ, Kemper K, ten Kate FJ, Offerhaus GJ, Richel DJ, van Lanschot JJ: Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma. Ann Surg 2005; 242:840-9.
16. Fux R, Schwab M, Thon KP, Gleiter CH, Fritz P: Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival. Clin Cancer Res 2005; 11:4754-60. (Pubitemid 41557195)
17. Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M, Sugihara K: Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 2004; 10:8465-71. (Pubitemid 40053411)
18. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH: Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001; 195:171-8.
19. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hanilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C: Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:979-94.
20. Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD, Munkarah AR: The effect of Cyclooxygenase -2 Expression on tumor vascularity in advanced stage ovarian serious carcinoma. Cancer 2003; 98:1423-9. (Pubitemid 37151497)
21. Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S, Yoshimura H, Tachibana M, Kubota H, Nagasue N: Cyclooxygenase-2 expression correlates with tumor neovascularisation and prognosis in human colorectal carcinoma patients. Clin Canc Res 2000; 6:4064-8.
22. Sheehan KM, Sheahan K, O'Donohue DP, MacSweeney F, Conroy RM, Fitzgerald DJ, Murray FE: The relationship between cyclooxygenase-2 expression and colorectal cancer. J Am Med Assoc 1999; 282:1254-7. (Pubitemid 29468497)
23. Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y, Nagawa H: Cyclooxygenaese-2 overexpression correlates with tumor recurrence, especially hematogenaous metastasis of colorectal cancer. Br J Canc 2000; 83:324-8.
24. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60:1306-11.
25. Liang JT, Huang KC, Jeng YM, Lee PH, Lai HS, Hsu HC: Microvessel density, cyclooxygenase-2, expression, K-ras mutation and p-53 overexpression in colonic cancer. Br J Surg 2004; 91(3):355-61.
26. Yamac D, Celenkoglu G, Coskun U, Akyurek N, Akcali Z, Dursun A, Koybasioglu F: Prognostic importance of Cox-2 expression in patients with colorectal cancer. Path Res Pract 2005; 201(7):497-502. (Pubitemid 41131390)
27. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM, Sugihara K: Size and invasion dependent increase of cyclooxygenase-2 levels in human colorectal carcinomas. Cancer Res 1998; 4823-6. (Pubitemid 28503676)
28. Wu AW, Gu J, Ji JF, Li ZF, Xu GW: Role of Cox-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients prognosis. World J Gastroenterol 2003; 9:1990-4. (Pubitemid 37168428)